QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
0
The U.S. remains one of the few countries without federally mandated paid parental leave, despite its major potential health benefits.
Nov 3, 2023
0
1
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further ...
Oct 23, 2023
0
0
Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress ...
Oct 18, 2023
0
0
Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer, and multiple myeloma, ...
Oct 4, 2023
0
62
A new research paper titled "Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas has been published in Oncotarget.
Sep 25, 2023
0
0
The American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That's one case about every five minutes. These types of malignancies originate in the female reproductive organs, ...
Sep 14, 2023
0
2
New research from QIMR Berghofer has found that the hormone testosterone may play an important role in the development of endometrial cancer.
Aug 25, 2023
0
37
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer. Endometrial cancer is the most common gynecological cancer and high levels of estrogen promote its development. ...
Aug 22, 2023
0
17
Maintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the American Society for Clinical Oncology Plenary ...
Jul 28, 2023
0
1
